Skip to main content
. Author manuscript; available in PMC: 2017 Jan 17.
Published in final edited form as: J Med Genet. 2014 Apr 8;51(6):375–387. doi: 10.1136/jmedgenet-2013-102248

Table 1.

Overview of identified NKX2-1 deletions and intragenic mutations

No. DNA sequence Size Protein
localisation
Protein level Inheritance
Phenotype
Affected
family
members*
Thyroid
dysfunction
Choreoathetosis/
muscular hypotonia
Pulmonary
malfunction
Sex
1 chr14:g
(36042742_36142540)del
99 798 bp Entire protein p.0 AD M 2 Yes Yes Yes M
2 chr14:g
(35138127_37502915)del
2 364 788 bp Entire protein p.0 AD M 1 Yes Yes No M
3 chr14:g
(35221080_36553158)del
1 332 078 bp Entire protein p.0 n/a n/a No Yes No F
4 chr14:g
(36058432_36825446)del
767 014 bp Entire protein p.0 n/a n/a Yes Yes No M
5 chr14:g
(34071433_36246414)del
2 174 981 bp Entire protein p.0 n/a n/a Yes Yes No F
6 chr14:g
(31766511_46944545)del
15 178 034 bp Entire protein p.0 n/a n/a Yes Yes No M
7 chr14:g
(35883857_38226260)del
2 342 403 bp Entire protein p.0 AD F 2 Yes Yes Yes M
8 chr14:g
(35989750_36754641)del
764 891 bp Entire protein p.0 De novo Nil Yes Yes Yes F
9 chr14:g
(35257445_35257464 + 35257487_35984627)del
727 181 bp Del excluding
NKX2-1
p.? De novo Nil Yes Yes No F
10 chr14:g
(35801941_35878529)del
76 588 bp Del excluding
NKX2-1
p.? AD M 2/F 2 No Yes No M
11 c.793delA NK2 p.Lys265LysfsX87 De novo Nil Yes Yes No M
12 c.712delGG NK2 p.Gly238ArgfsX170 AD F 2 Yes Yes Yes M
13 c.339delG TN-HD p.Trp113CysfsX16 De novo Nil No Yes No M
14 c.796delGA NK2 p.Asp266Argfs142X De novo Nil Yes Yes No F
15 c.157insC TN-HD p.Met53HisfsX355 De novo Nil Yes Yes Yes F
16 c.866_883delinsCTACA NK2-X p.Gln289ProfsX59 De novo Nil Yes Yes Yes M
17 c.544C>T HD p.Gln182X De novo Nil Yes Yes Yes F
18 c.261C>A TN-HD p.Cys87X AD F 2 Yes Yes Yes M
19 c.160C>T TN-HD p.Gln55X Father n/a; mother
WT
n/a Yes Yes No F
20 c.522C>G HD p.Tyr174X n/a n/a Yes Yes Yes M
21 c.338G>A TN-HD p.Trp113X n/a n/a Yes Yes No M
22 c.236C>A TN-HD p.Ser79X AD F 2 Yes Yes No F
23 c.204C>G TN-HD p.Tyr68X AD F 1 Yes Yes Yes M
24 [c.608C>G]+[c.613G>T] HD [p.Thr203Arg]+[p. Val205Phe] AD/de F 3 Yes Yes No M
25 c.613G>T HD p.Val205Phe De novo Nil Yes Yes No F
26 c.373+4A>G/r.373ins4 TN-HD (splice donor site) p.Ile155SerfsX126 De novo Nil Yes Yes Yes M
27 c.373+5G>C/r.338_373del35 TN-HD (splice donor site) p.Trp143CysfsX138 n/a n/a Yes Yes No M
28 chr14:g
(32446471_41666818)del
9.2 Mbp Entire protein p.0 De novo Nil Yes Yes Yes M
29 c.585nsGG HD p.Leu195GlyfsX3 De novo Nil Yes Yes Yes M
30 c.506C>A HD p.Ser169X n/a n/a Yes Yes No M
31 c.261C>A TN-HD p.Cys87X AD F 1 Yes Yes Yes M
32 c.613G>T HD p.Val205Phe De novo Nil Yes Yes Yes M

Nomenclature for mutations according to recommendations of the Human Genome Variation Society (http://www.hgvs.org/mutnomen/); reference sequence REFSEQ Isoform 2 NM_003317.3; P, entire protein; HD, homeodomain; NK2, NK2-specific domain; AD, autosomal-dominant; n/a, information not available; TN-HD, sequence between tin- and homeodomain; M, male; F, female;

*

excluding index patient; mutations 29–32 as reported previously by authors.8

The italicised values refer to cases that have not been identified in the present genotyping study, but earlier in the Krude et al 2002 study8.